Leukemia Research
Volume 27, Issue 9 , Pages 813-822 , September 2003

Expression of IL-18 and its receptor in human leukemia cells

Received 19 July 2002 ,Accepted 13 December 2002.

References 

  1. Lowenberg B, Touw IP. Hematopoietic growth factor and their receptors in acute leukemia. Blood. 1993;81:281–292
  2. Russell NH. Autocrine growth factors and leukemic haemopoiesis. Blood Rev. 1992;6:149–156
  3. Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 1998;10:259–264
  4. Mclnnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol. Today. 2000;21:312–315
  5. Taniguchi M, Nagaoka K, Kunikata T, Kayano T, Ymauchi H, Nakamura S, et al.  Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA. J. Immunol. Methods. 1997;206:107–113
  6. Wang Y, Li G, Zheng GG, Song YH, Wu KF. Detection and sequencing analysis of IL-18 expression in J6-1 leukemic cells. Leukemia Res. 2001;25:273–274
  7. Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikate T, et al.  Purification and characterization of human interleukin-18 receptor. J. Biol. Chem. 1997;272:25737–25742
  8. Parnet P, Garka KE, Bonnert TP, Dower SK, Sims JE. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/T2 and IL-1R AcP. J. Biol. Chem. 1996;271:3967–3970
  9. Born T, Thomassen LE, Bird TA, Sims JE. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 1998;273:29445–29450
  10. Hoshino K, Tsutsui H, Kawai T, Takeda K, Nakanishi K, Takeda Y, et al.  Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 1999;162:5041–5044
  11. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, et al.  IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFκB. Immunity. 1997;7:571–581
  12. Kunikata T, Torigoe K, Ushio S, Okura T, Ushio C, Yamauchi H, et al.  Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody. Cell Immunol. 1998;189:135–143
  13. Nakamura S, Otani T, Okura R, Ljiri Y, Motoda R, Kurimoto M, et al.  Expression and responsiveness of human interleukin-18 receptor (IL-18R) on hematopoietic cell lines. Leukemia. 2000;14:1052–1059
  14. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al.  Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French–American–British Cooperative Group. Ann. Int. Med. 1985;103:620–625
  15. Wu KF, Luka J, Joshi S, Pirruccello SJ, Masih A, Sharp JG. Characterization of a human herpes virus-6 (HHV-6) and Epstein-Barr virus (EBV) associated leukemic cell line, J6-1. Chin. J. Cancer Res. 1994;6:157–168
  16. Wu KF, Rao Q, Zheng GG, Geng YQ, Li M, Kong J, et al.  Enhancement of J6-1 human leukemic cell proliferation by cell–cell contact: role of an M-CSF-like membrane-associated growth factor. Leukemia Res. 1994;18:843–849
  17. Wu KF, Rao Q, Zheng GG, He ZH, Ying HG, Song YH, et al.  Enhancement of J6-1 human leukemic cell proliferation by MAF-J6-1 through a cell–cell contact mechanism. II. Role of an M-CSF receptor-like membrane protein. Leukemia Res. 1998;22:55–60
  18. Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, et al.  Bioactive IL-18 expression is up-regulated in Crohn’s disease. J. Immunol. 1999;163:143–151
  19. Zhang B, Wang Y, Zheng GG, Xiao-Tong M, Ge L, Ke-Fu W. Clinical significance of IL-18 over-expression in AML. Leukemia Res. 2002;26:887–892
  20. Zheng GG, Wu KF, Geng YQ, Kong J, Ayad A-K, Maria D, et al.  Expression of membrane-bound M-CSF in Hodgkin’s disease and other hematologic malignancies. Leukemia Lymphoma. 1999;32:339–344
  21. Chu RS, Askew D, Noss EH. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing. J. Immunol. 1999;163:1188–1194
  22. Chiaramonte MG, Hesse M, Cheever AW, Wynn TA. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J. Immunol. 2000;164:973–985
  23. Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 1998;70:281–312
  24. Ahn HJ, Maruo S, Tomura M, Mu J, Hamaoka T, Nakanishi K, et al.  A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J. Immunol. 1997;159:2125–2131
  25. Wu KF, Zhu YM, Rao Q, Chu JX, Zhao JM. Expression of transforming growth factor-beta. Ann. New York Acad. Sci. 1991;628:151
  26. Carter A, Draxler IS, Tatarsky I. Effect of interleukin-1, tumor necrosis factor-α, and interferon-α on the blast cells of acute myeloblastic leukemia. Am. J. Hematol. 1992;40:245–251
  27. Dunbar CE, Browder TM, Abram JS, Nienhuis AW. COOH-terminal-modified IL-3 is retained intracellularly and stimulates autocrine growth. Science. 1989;245:1493–1496
  28. Bejcek BE, Li DY, Deuel TF. Transformation by v-sis occurs by an internal autoactivation mechanism. Science. 1989;245:1496–1499
  29. Tang SS, Zheng GG, Wu KF, Chen GB, Liu HZ, Rao Q. Autocrine and possible intracrine regulation of HL-60 cell proliferation by M-CSF. Leukemia Res. 2001;25:1107–1114
  30. Krueger GR, Kudlimay D, Ramon A, Klueppelberg U, Schumacher K. Demonstration of active and latent Epstein-Barr virus and human herpevirus-6 infections in bone marrow cells of patients with myelodysplasia and chronic myeloproliferative diseases. In Vivo. 1994;8:533–542
  31. Krueger GR, Huetter ML, Rojo J, Romero M, Cruz-Ortiz H. Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin’s and Kikuchi’s diseases and their relation to proliferation and apoptosis. Anticancer Res. 2001;21:2155–2161
  32. Mizuno S, Akashi K, Ohshima K, Iwasaki H, Miyamoto T, Uchida N, et al.  Interferon-gamma prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. Blood. 1999;93:3494–3504
  33. Konishi K, Tanabe F, Taniguchi M, Yamauchi H, Tanimoto T, Ikeda M, et al.  A simple and sensitive bioassay for the detection of human interleukin-18/interferon-gamma-inducing factor using human myelomonocytic KG-1 cells. J. Immunol. Methods. 1997;209:187–191
  34. Sareneva T, Julkunen I, Matikainen S. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 2000;165:1933–1938

PII: S0145-2126(03)00005-5

doi: 10.1016/S0145-2126(03)00005-5

Leukemia Research
Volume 27, Issue 9 , Pages 813-822 , September 2003

Article Tools

* Image Usage & Resolution